ARCHIVES

FDA News: ODAC Recommends Taxol For KS; Votes Against 2 Other Drugs

This article is from The Cancer Letter archive.

Vol. 23 No. 26 | July 4, 1997

Download PDF Visit The Full Archive

Related Articles

White House Staff Member Reportedly Says Political Screening Being Carried Out On NCAB Nominations

May 28, 1982

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

May 22, 1981

Former NCI Executive Lands Key Senate Staff Position

February 4, 1977

Cooperative Group Chairmen Unhappy Over Contracts They Missed, NCI Protocol Review

January 13, 1978

Community Cancer Centers Selected For Pilot Program.

June 22, 2007

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

October 25, 2013